Muutke küpsiste eelistusi

E-raamat: Behavioral Neurobiology of Psychedelic Drugs

Edited by , Edited by , Edited by
Teised raamatud teemal:
  • Formaat - PDF+DRM
  • Hind: 246,38 €*
  • * hind on lõplik, st. muud allahindlused enam ei rakendu
  • Lisa ostukorvi
  • Lisa soovinimekirja
  • See e-raamat on mõeldud ainult isiklikuks kasutamiseks. E-raamatuid ei saa tagastada.
Behavioral Neurobiology of Psychedelic DrugsSuurem pilt
Teised raamatud teemal:

DRM piirangud

  • Kopeerimine (copy/paste):

    ei ole lubatud

  • Printimine:

    ei ole lubatud

  • Kasutamine:

    Digitaalõiguste kaitse (DRM)
    Kirjastus on väljastanud selle e-raamatu krüpteeritud kujul, mis tähendab, et selle lugemiseks peate installeerima spetsiaalse tarkvara. Samuti peate looma endale  Adobe ID Rohkem infot siin. E-raamatut saab lugeda 1 kasutaja ning alla laadida kuni 6'de seadmesse (kõik autoriseeritud sama Adobe ID-ga).

    Vajalik tarkvara
    Mobiilsetes seadmetes (telefon või tahvelarvuti) lugemiseks peate installeerima selle tasuta rakenduse: PocketBook Reader (iOS / Android)

    PC või Mac seadmes lugemiseks peate installima Adobe Digital Editionsi (Seeon tasuta rakendus spetsiaalselt e-raamatute lugemiseks. Seda ei tohi segamini ajada Adober Reader'iga, mis tõenäoliselt on juba teie arvutisse installeeritud )

    Seda e-raamatut ei saa lugeda Amazon Kindle's. 

This volume brings together the latest basic and clinical research examining the effects and underlying mechanisms of psychedelic drugs. Examples of drugs within this group include LSD, psilocybin, and mescaline. Despite their structural differences, these compounds produce remarkably similar experiences in humans and share a common mechanism of action.  Commonalities among the substances in this family are addressed both at the clinical and phenomenological level and at the basic neurobiological mechanism level. To the extent possible, contributions relate the clinical and preclinical findings to one another across species. The volume addresses both the risks associated with the use of these drugs and the potential medical benefits that might be associated with these and related compounds.

Arvustused

This book brings together the latest basic and clinical research into the underlying mechanism of action, effects, and possible clinical uses of psychedelic drugs. It brings together current knowledge regarding this class of drugs pharmacology, neurobiological effects, subjective experience, and therapeutic effects. It brings together preclinical and clinical data, which will be of interest to anyone involved with or curious about this category of drugs. (Michael Easton, Doody's Book Reviews, September, 2018)

Chemistry and Structure-Activity Relationships of Psychedelics
1(44)
David E. Nichols
Hallucinogens and Serotonin 5-HT2A Receptor-Mediated Signaling Pathways
45(30)
Juan F. Lopez-Gimenez
Javier Gonzalez-Maeso
Effects of Hallucinogens on Neuronal Activity
75(32)
L. Llado-Pelfort
P. Celada
M.S. Riga
E. Troyano-Rodriguez
N. Santana
F. Artigas
Interactions of Hallucinogens with the Glutamatergic System: Permissive Network Effects Mediated Through Cortical Layer V Pyramidal Neurons
107(30)
Gerard J. Marek
The Effects of Hallucinogens on Gene Expression
137(22)
David A. Martin
Charles D. Nichols
Effect of Hallucinogens on Unconditioned Behavior
159(42)
Adam L. Halberstadt
Mark A. Geyer
Hallucinogens in Drug Discrimination
201(20)
Lisa E. Baker
Phenomenology, Structure, and Dynamic of Psychedelic States
221(36)
Katrin H. Preller
Franz X. Vollenweider
Serotonergic Hallucinogen-Induced Visual Perceptual Alterations
257(26)
Michael Kometer
Franz X. Vollenweider
New World Tryptamine Hallucinogens and the Neuroscience of Ayahuasca
283(30)
Dennis McKenna
Jordi Riba
Experimental Psychosis Research and Schizophrenia---Similarities and Dissimilarities in Psychopathology
313(20)
Leo Hermle
Rainer Kraehenmann
A Review of Hallucinogen Persisting Perception Disorder (HPPD) and an Exploratory Study of Subjects Claiming Symptoms of HPPD
333(28)
John H. Halpern
Arturo G. Lerner
Torsten Passie
Therapeutic Applications of Classic Hallucinogens
361(32)
Michael P. Bogenschutz
Stephen Ross
Classic Hallucinogens and Mystical Experiences: Phenomenology and Neural Correlates
393
Frederick S. Barrett
Roland R. Griffiths
Erratum to: Phenomenology, Structure, and Dynamic of Psychedelic States El
1
Katrin H. Preller
Franz X. Vollenweider
Lisainfo e-raamatute kohta Lisainfo e-raamatute kohta
Püsilink: https://www.kriso.ee/db/97836625588052e.html